Skip to main content

Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens

Publication ,  Conference
Cerdena, S; Mackey, MC; Kuchibhatla, M; Rizzieri, DA; Moorman, MT
Published in: BLOOD
December 7, 2017

Duke Scholars

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 7, 2017

Volume

130

Location

Atlanta, GA

Publisher

AMER SOC HEMATOLOGY

Conference Name

59th Annual Meeting of the American-Society-of-Hematology (ASH)

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cerdena, S., Mackey, M. C., Kuchibhatla, M., Rizzieri, D. A., & Moorman, M. T. (2017). Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens. In BLOOD (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.
Cerdena, Sebastian, Melissa C. Mackey, Maragatha Kuchibhatla, David A. Rizzieri, and Meredith T. Moorman. “Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens.” In BLOOD, Vol. 130. AMER SOC HEMATOLOGY, 2017.

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 7, 2017

Volume

130

Location

Atlanta, GA

Publisher

AMER SOC HEMATOLOGY

Conference Name

59th Annual Meeting of the American-Society-of-Hematology (ASH)

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology